BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 15972634)

  • 1. A His-155 to Tyr polymorphism confers gain-of-function to the human P2X7 receptor of human leukemic lymphocytes.
    Cabrini G; Falzoni S; Forchap SL; Pellegatti P; Balboni A; Agostini P; Cuneo A; Castoldi G; Baricordi OR; Di Virgilio F
    J Immunol; 2005 Jul; 175(1):82-9. PubMed ID: 15972634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Thr357 to Ser polymorphism in homozygous and compound heterozygous subjects causes absent or reduced P2X7 function and impairs ATP-induced mycobacterial killing by macrophages.
    Shemon AN; Sluyter R; Fernando SL; Clarke AL; Dao-Ung LP; Skarratt KK; Saunders BM; Tan KS; Gu BJ; Fuller SJ; Britton WJ; Petrou S; Wiley JS
    J Biol Chem; 2006 Jan; 281(4):2079-86. PubMed ID: 16263709
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An Arg307 to Gln polymorphism within the ATP-binding site causes loss of function of the human P2X7 receptor.
    Gu BJ; Sluyter R; Skarratt KK; Shemon AN; Dao-Ung LP; Fuller SJ; Barden JA; Clarke AL; Petrou S; Wiley JS
    J Biol Chem; 2004 Jul; 279(30):31287-95. PubMed ID: 15123679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms that were identified in affective mood disorders affect ATP-activated P2X7 receptor functions.
    Roger S; Mei ZZ; Baldwin JM; Dong L; Bradley H; Baldwin SA; Surprenant A; Jiang LH
    J Psychiatr Res; 2010 Apr; 44(6):347-55. PubMed ID: 19931869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Polymorphism in the P2X7 receptor gene and survival in chronic lymphocytic leukaemia.
    Thunberg U; Tobin G; Johnson A; Söderberg O; Padyukov L; Hultdin M; Klareskog L; Enblad G; Sundström C; Roos G; Rosenquist R
    Lancet; 2002 Dec; 360(9349):1935-9. PubMed ID: 12493261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 1513A/C polymorphism in the P2X7 receptor gene in chronic lymphocytic leukemia: absence of correlation with clinical outcome.
    Nückel H; Frey UH; Dürig J; Dührsen U; Siffert W
    Eur J Haematol; 2004 Apr; 72(4):259-63. PubMed ID: 15089763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific detection of non-functional human P2X(7) receptors in HEK293 cells and B-lymphocytes.
    Barden JA; Sluyter R; Gu BJ; Wiley JS
    FEBS Lett; 2003 Mar; 538(1-3):159-62. PubMed ID: 12633871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and characterization of a novel variant of the human P2X(7) receptor resulting in gain of function.
    Sun C; Chu J; Singh S; Salter RD
    Purinergic Signal; 2010 Mar; 6(1):31-45. PubMed ID: 19838818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The antibiotic polymyxin B modulates P2X7 receptor function.
    Ferrari D; Pizzirani C; Adinolfi E; Forchap S; Sitta B; Turchet L; Falzoni S; Minelli M; Baricordi R; Di Virgilio F
    J Immunol; 2004 Oct; 173(7):4652-60. PubMed ID: 15383600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: evidence for nonfunctional P2X(7) receptors.
    Gu BJ; Zhang WY; Bendall LJ; Chessell IP; Buell GN; Wiley JS
    Am J Physiol Cell Physiol; 2000 Oct; 279(4):C1189-97. PubMed ID: 11003599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Glu-496 to Ala polymorphism leads to loss of function of the human P2X7 receptor.
    Gu BJ; Zhang W; Worthington RA; Sluyter R; Dao-Ung P; Petrou S; Barden JA; Wiley JS
    J Biol Chem; 2001 Apr; 276(14):11135-42. PubMed ID: 11150303
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A loss-of-function polymorphic mutation in the cytolytic P2X7 receptor gene and chronic lymphocytic leukaemia: a molecular study.
    Wiley JS; Dao-Ung LP; Gu BJ; Sluyter R; Shemon AN; Li C; Taper J; Gallo J; Manoharan A
    Lancet; 2002 Mar; 359(9312):1114-9. PubMed ID: 11943260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The P2X7 receptor gene A1513C polymorphism does not contribute to risk of familial or sporadic chronic lymphocytic leukemia.
    Sellick GS; Rudd M; Eve P; Allinson R; Matutes E; Catovsky D; Houlston RS
    Cancer Epidemiol Biomarkers Prev; 2004 Jun; 13(6):1065-7. PubMed ID: 15184265
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1513A>C polymorphism in the P2X7 receptor gene in patients with papillary thyroid cancer: correlation with histological variants and clinical parameters.
    Dardano A; Falzoni S; Caraccio N; Polini A; Tognini S; Solini A; Berti P; Di Virgilio F; Monzani F
    J Clin Endocrinol Metab; 2009 Feb; 94(2):695-8. PubMed ID: 19017759
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Point mutations confer loss of ATP-induced human P2X(7) receptor function.
    Worthington RA; Smart ML; Gu BJ; Williams DA; Petrou S; Wiley JS; Barden JA
    FEBS Lett; 2002 Feb; 512(1-3):43-6. PubMed ID: 11852049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis.
    Fernando SL; Saunders BM; Sluyter R; Skarratt KK; Goldberg H; Marks GB; Wiley JS; Britton WJ
    Am J Respir Crit Care Med; 2007 Feb; 175(4):360-6. PubMed ID: 17095747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two haplotypes of the P2X(7) receptor containing the Ala-348 to Thr polymorphism exhibit a gain-of-function effect and enhanced interleukin-1beta secretion.
    Stokes L; Fuller SJ; Sluyter R; Skarratt KK; Gu BJ; Wiley JS
    FASEB J; 2010 Aug; 24(8):2916-27. PubMed ID: 20360457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxygen/glucose deprivation increases the integration of recombinant P2X7 receptors into the plasma membrane of HEK293 cells.
    Milius D; Gröger-Arndt H; Stanchev D; Lange-Dohna C; Rossner S; Sperlagh B; Wirkner K; Illes P
    Toxicology; 2007 Aug; 238(1):60-9. PubMed ID: 17618031
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The His155Tyr (489C>T) single nucleotide polymorphism of P2RX7 gene confers an enhanced function of P2X7 receptor in immune cells from patients with rheumatoid arthritis.
    Portales-Cervantes L; Niño-Moreno P; Salgado-Bustamante M; García-Hernández MH; Baranda-Candido L; Reynaga-Hernández E; Barajas-López C; González-Amaro R; Portales-Pérez DP
    Cell Immunol; 2012; 276(1-2):168-75. PubMed ID: 22703695
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maitotoxin and P2Z/P2X(7) purinergic receptor stimulation activate a common cytolytic pore.
    Schilling WP; Wasylyna T; Dubyak GR; Humphreys BD; Sinkins WG
    Am J Physiol; 1999 Oct; 277(4):C766-76. PubMed ID: 10516107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.